Prevention of Congenital Rubella

Overview

Journal Can Med Assoc J

Specialty General Medicine

Date 1977 Jul 23

PMID 326368

Citations 3

Authors

J P Welch

Affiliations

Soon will be listed here.

Abstract

The vaccine of choice for rubella vaccination is considered to be RA 27/3, based on frequency of side effects, duration of immunity, antigenic potential and rate of reinfection by wild virus. The most appropriate individuals to be vaccinated are prepubertal schoolgirls and susceptible members of other high-risk groups, and a nationwide immunization program is suggested. Premarital determination of rubella-immune status should be mandatory for all women of childbearing age. A favourable cost/benefit ratio for rubella vaccination seems highly probable. The use of a rubella "fact sheet" to provide education and information for those at risk is strongly recommended.

Citing Articles

Rubella susceptibility: a solo family physician survey.

Bowen-Roberts P Can Fam Physician. 2011; 26:81-2.

PMID: 21297842 PMC: 2383545.

Rubella screening and immunization: its history and future-an ongoing challenge.

Gerace T Can Fam Physician. 2011; 33:111-5.

PMID: 21267342 PMC: 2218305.

Rubella vaccination: a course becomes clear.

Spika J, Clogg D Can Med Assoc J. 1983; 129(2):106-7, 110.

PMID: 6861051 PMC: 1875246.

References

HAMBLING M . Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age. Lancet. 1975; 1(7916):1130-3. DOI: 10.1016/s0140-6736(75)92514-3. View

Horstmann D . Need for monitoring vaccinated populations for immunity levels. Prog Med Virol. 1973; 16:215-40. View

Judson F, Shaw B, VERNON Jr T . Mandatory premarital rubella serologic testing in Colorado. A preliminary report. JAMA. 1974; 229(9):1200-2. View

McLean D . The rubella situation in Canada--1972. Can J Public Health. 1972; 63(5):385-91. View

Cooper L, Krugman S . Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol. 1967; 77(4):434-9. DOI: 10.1001/archopht.1967.00980020436004. View

DUDGEON J . The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps. Practitioner. 1975; 215(1287):299-309. View

FAULKNER R, Gough D . Rubella 1974 and its aftermath, congenital rubella syndrome. Can Med Assoc J. 1976; 114(2):115-9. PMC: 1956819. View

Katz M . Editorial: Rubella vaccine. J Pediatr. 1974; 84(4):615-6. DOI: 10.1016/s0022-3476(74)80705-5. View

Wallace R, ISACSON P . Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines. Am J Dis Child. 1972; 124(4):536-8. DOI: 10.1001/archpedi.1972.02110160074007. View

10.

Liebhaber H, Ingalls T, LE BOUVIER G, Horstmann D . Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years. Am J Dis Child. 1972; 123(2):133-6. View

11.

Joncas J . Letter: Rubella immunization. Can Med Assoc J. 1974; 111(9):907, 909, 911. PMC: 1955882. View

12.

Rachelefsky G, Herrmann K . Congenital rubella surveillance following epidemic rubella in a partially vaccinated community. J Pediatr. 1974; 84(4):474-8. DOI: 10.1016/s0022-3476(74)80663-3. View

13.

Krugman S, Katz S . Editorial: Rubella immunization: a five-year progress report. N Engl J Med. 1974; 290(24):1375-6. DOI: 10.1056/NEJM197406132902410. View

14.

Plotkin S, FARQUHAR J, Ogra P . Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA. 1973; 225(6):585-90. DOI: 10.1001/jama.225.6.585. View

15.

Horstmann D, Pajot T, Liebhaber H . Epidemiology of rubella. Subclinical infection and occurrence of reinfection. Am J Dis Child. 1969; 118(1):133-6. View

16.

FREESTONE D, Reynolds G, MCKINNON J, PRYDIE J . Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley. Br J Prev Soc Med. 1975; 29(4):258-61. PMC: 478923. DOI: 10.1136/jech.29.4.258. View

17.

Stoffman J, Wolfish M . The susceptibility of adolescent girls to rubella. Observations on 297 girls in Toronto. Clin Pediatr (Phila). 1976; 15(7):625-6. DOI: 10.1177/000992287601500709. View

18.

Grillner L . Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines. J Infect Dis. 1976; 133(6):637-41. DOI: 10.1093/infdis/133.6.637. View

19.

Modlin J, Herrmann K, Eddins D, Hayden G . Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med. 1976; 294(18):972-4. DOI: 10.1056/NEJM197604292941802. View

20.

Horstmann D . Controlling rubella: problems and perspectives. Ann Intern Med. 1975; 83(3):412-7. DOI: 10.7326/0003-4819-83-3-412. View